Today's Rundown Hahn: Permanently adopting R&D-accelerating COVID-19 measures is a top FDA priority [Sponsored] Salesforce proactively helps providers re-engage patients and reschedule elective procedures and services delayed by the COVID-19 crisis CVS Pharmacy is testing self-driving vehicles for medication delivery Pfizer to funnel $500M into biotechs, offering 'crucial capital' during the COVID-19 crisis UnitedHealth exec on telehealth use, reimbursement: 'The genie is out of the bottle' Biopharma roundup: Fred Hutch fights COVID, too; Indian drugmakers stalled on remdesivir Healthcare roundup: Blue Cross NC waives MA copays for primary care through end of 2020 CMS increases penalties following nearly 26K COVID-19 nursing home deaths In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center Drugmakers struggle to meet demand for antidepressant Zoloft amid COVID-19 How Cambia Health Solutions is tackling critical health disparities amid COVID-19 Featured Story | | | Tuesday, June 2, 2020 FDA Commissioner Stephen Hahn, M.D., has vowed to permanently adopt COVID-19-driven changes that make reviews and authorizations faster. Hahn made the commitment in a speech that called on the FDA to learn from the crisis to enact lasting policies that accelerate drug development. |
|
|---|
|
| | | Monday, May 25, 2020 Many elective procedures were postponed due to COVID-19, but with the Salesforce Accelerate Elective Procedures solution, providers are able to re-engage patients and reschedule elective procedures. |
|
|---|
|
Top Stories Tuesday, June 2, 2020 CVS Health began testing drone delivery last year, and now the company is moving on to try self-driving vehicles. The pharmacy retail giant is working with autonomous vehicle startup Nuro to test prescription delivery in a pilot market. Tuesday, June 2, 2020 In a pandemic world, the biotech funding environment couldn’t look brighter, and today Pfizer shone its own light. Tuesday, June 2, 2020 Telehealth companies have struggled for years to convince payers to reimburse for their services—and then to convince consumers to use the virtual healthcare offerings. Now, it appears, the industry has truly arrived, experts said during a FierceHealthPayer event Tuesday. Tuesday, June 2, 2020 Bristol Myers vet and Fred Hutch chief Tom Lynch figures the leading cancer center can play a role in fighting COVID-19. Houston Methodist released phase 1 results for its COVID plasma therapy. Indian drugmakers with remdesivir licenses are stalled. And Merck CEO Ken Frazier urged Americans to work together as they face twin crises. Tuesday, June 2, 2020 Follow along with the latest COVID-19 news straight from the FierceHealthcare team. Monday, June 1, 2020 The Trump administration has increased enforcement of states and nursing homes that have been repeat offenders of not following infection control practices. Tuesday, June 2, 2020 From chief scientific officer of Bristol Myers Squibb (back when it still had a hyphen) to running one of the biggest cancer research organizations in the world is a major career shift and challenge at the best of times. Tuesday, June 2, 2020 Antidepressant Zoloft and its generics are in short supply as the COVID-19 pandemic has boosted prescriptions and strained manufacturing. Certain drugmakers aren't able to get their hands on active pharmaceutical ingredients. Tuesday, June 2, 2020 The COVID-19 pandemic has forced health plans to take the resources they have and adapt them to fit the needs of a global health crisis. |
